Minamestane Explained

Minamestane (INN (former developmental code name FCE-24,928) is a steroidal aromatase inhibitor which was under development by Farmitalia-Carlo Erba as an antineoplastic agent in the mid-1990s but was never marketed.[1] [2] [3]

Unlike other steroidal aromatase inhibitors such as formestane and exemestane, minamestane does not have androgenic properties.

See also

Notes and References

  1. Book: F.. Macdonald . Dictionary of Pharmacological Agents . 20 May 2012 . 1997 . CRC Press . 978-0-412-46630-4 . 1357.
  2. Di Salle E, Briatico G, Giudici D, etal . Novel aromatase and 5 alpha-reductase inhibitors . The Journal of Steroid Biochemistry and Molecular Biology . 49 . 4–6 . 289–94 . June 1994 . 8043491 . 10.1016/0960-0760(94)90270-4. 54350143 .
  3. Combs . Donald W . Review Oncologic, Endocrine & Metabolic: Recent developments in aromatase inhibitors . Expert Opinion on Therapeutic Patents . 5 . 6 . 1995 . 529533 . 1354-3776 . 10.1517/13543776.5.6.529.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Minamestane".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.